Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14044 | 732 | 27.5 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
483 | 14947 | GANGLIOSIDES//SIALYLTRANSFERASE//SIALIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ABO BLOOD GROUP | Author keyword | 51 | 42% | 13% | 93 |
2 | ABO GENE | Author keyword | 49 | 94% | 2% | 17 |
3 | ABO GENOTYPING | Author keyword | 30 | 84% | 2% | 16 |
4 | ABO BLOOD GROUP SYSTEM | Author keyword | 18 | 42% | 5% | 33 |
5 | ABO | Author keyword | 14 | 26% | 6% | 46 |
6 | CIS AB | Author keyword | 8 | 100% | 1% | 5 |
7 | GENETIC HOMOZYGOSITY | Author keyword | 8 | 100% | 1% | 5 |
8 | ABO GENOTYPE | Author keyword | 7 | 64% | 1% | 7 |
9 | BLOOD GROUP | Author keyword | 7 | 17% | 5% | 37 |
10 | ABO BLOOD GROUPS | Author keyword | 7 | 26% | 3% | 22 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABO BLOOD GROUP | 51 | 42% | 13% | 93 | Search ABO+BLOOD+GROUP | Search ABO+BLOOD+GROUP |
2 | ABO GENE | 49 | 94% | 2% | 17 | Search ABO+GENE | Search ABO+GENE |
3 | ABO GENOTYPING | 30 | 84% | 2% | 16 | Search ABO+GENOTYPING | Search ABO+GENOTYPING |
4 | ABO BLOOD GROUP SYSTEM | 18 | 42% | 5% | 33 | Search ABO+BLOOD+GROUP+SYSTEM | Search ABO+BLOOD+GROUP+SYSTEM |
5 | ABO | 14 | 26% | 6% | 46 | Search ABO | Search ABO |
6 | CIS AB | 8 | 100% | 1% | 5 | Search CIS+AB | Search CIS+AB |
7 | GENETIC HOMOZYGOSITY | 8 | 100% | 1% | 5 | Search GENETIC+HOMOZYGOSITY | Search GENETIC+HOMOZYGOSITY |
8 | ABO GENOTYPE | 7 | 64% | 1% | 7 | Search ABO+GENOTYPE | Search ABO+GENOTYPE |
9 | BLOOD GROUP | 7 | 17% | 5% | 37 | Search BLOOD+GROUP | Search BLOOD+GROUP |
10 | ABO BLOOD GROUPS | 7 | 26% | 3% | 22 | Search ABO+BLOOD+GROUPS | Search ABO+BLOOD+GROUPS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | O ALLELE | 79 | 94% | 4% | 29 |
2 | GROUP ABO LOCUS | 23 | 86% | 2% | 12 |
3 | GROUP ALLELES | 21 | 73% | 2% | 16 |
4 | GROUP SYSTEM | 18 | 22% | 10% | 76 |
5 | O ALLELES | 14 | 64% | 2% | 14 |
6 | HYBRID ALLELE | 12 | 86% | 1% | 6 |
7 | GROUP ANTIGENS | 11 | 20% | 6% | 47 |
8 | GROUP B TRANSFERASES | 10 | 73% | 1% | 8 |
9 | ABO LOCUS | 10 | 48% | 2% | 15 |
10 | B SUBGROUP | 8 | 100% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
ABO(H) blood groups and vascular disease: a systematic review and meta-analysis | 2008 | 128 | 39 | 36% |
ABO Blood Group and Risk of Pancreatic Cancer: A Study in Shanghai and Meta-Analysis | 2013 | 12 | 40 | 55% |
ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis | 2014 | 2 | 60 | 73% |
ABO blood group and thrombotic vascular disease | 2014 | 4 | 63 | 44% |
What a difference 2 Nucleotides make: A short review of ABO genetics | 2005 | 16 | 38 | 87% |
The ABO blood group gene: A locus of considerable genetic diversity | 2001 | 72 | 69 | 78% |
Beyond immunohaematology: the role of the ABO blood group in human diseases | 2013 | 6 | 66 | 53% |
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer | 1999 | 138 | 58 | 34% |
Polymorphism and recombination events at the ABO locus: a major challenge for genomic ABO blood grouping strategies | 2001 | 59 | 88 | 75% |
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? | 2006 | 101 | 63 | 19% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COPENHAGEN MALE STUDY EPIDEMIOL UNIT | 2 | 67% | 0.3% | 2 |
2 | IMMUNOGENET MOL LIMT | 2 | 67% | 0.3% | 2 |
3 | MEDICOLEGAL SECT | 2 | 67% | 0.3% | 2 |
4 | CLIN ENVIRONM OCCUPAT MED | 2 | 43% | 0.4% | 3 |
5 | EA3034 | 1 | 33% | 0.3% | 2 |
6 | DIPARTIMENTO MED TRASFUS EMATOL | 1 | 23% | 0.4% | 3 |
7 | BLOOD MANAGEMENT | 1 | 50% | 0.1% | 1 |
8 | DIRECTORATE MED EDUC | 1 | 50% | 0.1% | 1 |
9 | DYSLIPIDEMIA CARDIOVASC DISSTATE C | 1 | 50% | 0.1% | 1 |
10 | ETAB TRANSFUS SANGUINE PYRENEES GARONNE | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000198127 | FUCOSYLTRANSFERASE//LEWIS Y ANTIGEN//FUT2 |
2 | 0.0000175762 | ADV STUDIES LIFE SCI//NON SECRETORS//SOCIO ECONOMICAL LEVEL |
3 | 0.0000140810 | GLYCOTECHNOL BUSINESS UNIT//STRUCT GLYCOBIOL SECT//BACTERIAL SIALYLTRANSFERASE |
4 | 0.0000134587 | MISATTRIBUTED PATERNITY//APPARENT HOMOZYGOSITY//NONPATERNITY |
5 | 0.0000078002 | WEAK D//RH BLOOD GROUP SYSTEM//RH BLOOD GROUP |
6 | 0.0000077463 | BENAVIDES CANC//COLORECTOANAL SURG//HEPATITIS A ACUTE |
7 | 0.0000072592 | ARCTIC HABITATS//ANTISTAPHYLOCOCCAL ACTIVITIES//CYCLO L LEU L ARG |
8 | 0.0000070108 | UF SIDA//KODECYTE//ESA CNRS 6033 |
9 | 0.0000056997 | ABO INCOMPATIBLE//ABO INCOMPATIBLE KIDNEY TRANSPLANTATION//ABO INCOMPATIBILITY |
10 | 0.0000054101 | UNIDAD NEONATOL//INDIANS SOUTH AMERICAN//GENETICS MEDICAL |